Study | Age | Presentation | Lab findings | NCS | Other | Treatment | Outcome | |
---|---|---|---|---|---|---|---|---|
1 | Ng et al. (1997) | 58/M | Symmetric weakness, hyporeflexia, asthma | Eosinophilia, raised ESR, P-ANCA + ve | Mixed demyelinating polyneuropathy, multifocal absent F waves | Lung infiltrates | Steroids, cyclophosphamide, plasma exchange | Expired |
2 | Kevent et al. (1998) | 57/M | Symmetric weakness, hyporeflexia | Raised ESR, P-ANCA + ve | Mixed demyelinating polyneuropathy, multifocal absent F waves | Nephritis | Steroids | Improved |
3 | Riva et al. (2008) | 51/F | Asthma, nasal polyposis, symmetric weakness, hyporeflexia | Eosinophilia, raised ESR, P-ANCA -ve | Motor asymmetric axonal polyneuropathy, multifocal absent F waves | IVIg, steroids | Improved | |
4 | Djukic et al. (2008) | 74/M | Asthma, symmetric weakness, hyporeflexia | Eosinophilia | Mixed demyelinating polyneuropathy, multifocal absent F waves | Steroids, cyclophosphamide | Improved | |
5 | Lemarroy et al. (2015) | 36/F | Asthma, pansinusitis, purpura, symmetric weakness, hyporeflexia | Eosinophilia, raised ESR, P-ANCA + ve | Motor asymmetric axonal polyneuropathy | Steroids, cyclophosphamide | Improved | |
6 | Bortolani et al. (2016) | 68/F | Asthma, symmetric weakness, areflexia | Eosinophilia, P-ANCA + ve | Motor axonal polyneuropathy | Steroids | Improved | |
7 | Yadav et al. (2017) | 57/F | Asthma, symmetric weakness, hyporeflexia | Eosinophilia, proteinuria, P-ANCA + ve | Severe axonal and demyelinating polyneuropathy | Nephritis | Steroids, cyclophosphamide | Improved |
8 | Kim et al. (2018) | 51/F | Asthma, asymmetric weakness, hyporeflexia, purpura | Eosinophilia, maxillary sinusitis, P-ANCA + ve | Sensory, motor, axonal, polyneuropathy | Steroids | Improved |